Bookmarks
ID-439: Making the economic case for remote glucose monitoring during chemotherapy
Safe People
Organisation name
Chelsea and Westminster NHS Foundation Trust
Applicant name(s)
Funders/ Sponsors
Safe Projects
Project ID
ID-439
Lay summary
This data will allow estimates to be made regarding the costs and impact of initiating glucose monitoring to be made, facilitating business cases for implementation of a remote glucose monitoring solution.
Public benefit statement
Patients can learn to check their glucose levels at home using a simple finger prick test (which can be taught whilst at hospital receiving cancer treatment). A mobile app sends these results to the Oncology team, who can monitor them. If someone has very high glucose levels, they can get assessed and treated on the same day to avoid hospital admission. Those with moderately high levels can get dietary advice and start treatment with their next chemotherapy cycle.
Other approval committees
Latest approval date
12/12/2024
Safe Data
Dataset(s) name
Safe Setting
Access type
TRE